New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Adverse cardiac events in patients with coronary stents undergoing noncardiac surgery: a systematic review
Adverse cardiac events in patients with coronary stents undergoing noncardiac surgery: a systematic review AMERICAN JOURNAL OF SURGERY Hollis, R. H., Graham, L. A., Richman, J. S., Deierhoi, R. J., Hawn, M. T. 2012; 204 (4): 494-501Abstract
When patients with drug-eluting stents (DES) present for surgery, current guidelines recommend delaying elective surgeries until 1 year of dual antiplatelet therapy has been completed.We performed a systematic literature review of the major adverse cardiac events (MACE) associated with noncardiac surgery in patients with DES.Twenty-eight of 358 studies met inclusion criteria. Overall, MACE rates decreased as time to surgery increased and varied from 0% to 18% for surgeries within 1 year as compared with 0% to 12% for surgery more than 1 year after a stent. In addition, the current literature showed limited evidence for a protective effect of continuing perioperative dual antiplatelet therapy on MACE rates.The current literature supports a significant decrease in MACE when surgery is performed 1 year after DES placement; however, the level of evidence is weak. Larger studies are needed to determine the safe interval for surgery after stent placement.
View details for DOI 10.1016/j.amjsurg.2012.04.008
View details for Web of Science ID 000309805500014
View details for PubMedID 22867724